Advertisement
Research Article

Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine

  • Julia Romanova equal contributor,

    equal contributor Contributed equally to this work with: Julia Romanova, Brigitte M. Krenn

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Brigitte M. Krenn equal contributor,

    equal contributor Contributed equally to this work with: Julia Romanova, Brigitte M. Krenn

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Markus Wolschek,

    Affiliations: Avir Green Hills Biotechnology AG, Vienna, Austria, Department of Surgery, University of Vienna Medical School, Vienna, Austria

    X
  • Boris Ferko,

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Ekaterina Romanovskaja-Romanko,

    Affiliation: Influenza Research Institute, Russian Academy of Medical Sciences, St. Petersburg, Russia

    X
  • Alexander Morokutti,

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Anna-Polina Shurygina,

    Affiliation: Influenza Research Institute, Russian Academy of Medical Sciences, St. Petersburg, Russia

    X
  • Sabine Nakowitsch,

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Tanja Ruthsatz,

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Bettina Kiefmann,

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Ulrich König,

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Michael Bergmann,

    Affiliation: Department of Surgery, University of Vienna Medical School, Vienna, Austria

    X
  • Monika Sachet,

    Affiliation: Department of Surgery, University of Vienna Medical School, Vienna, Austria

    X
  • Shobana Balasingam,

    Affiliation: Retroscreen Virology Ltd., Centre for Infectious Diseases, Bart's and the London, Queen Mary's School of Medicine and Dentistry, London, United Kingdom

    X
  • Alexander Mann,

    Affiliation: Retroscreen Virology Ltd., Centre for Infectious Diseases, Bart's and the London, Queen Mary's School of Medicine and Dentistry, London, United Kingdom

    X
  • John Oxford,

    Affiliation: Retroscreen Virology Ltd., Centre for Infectious Diseases, Bart's and the London, Queen Mary's School of Medicine and Dentistry, London, United Kingdom

    X
  • Martin Slais,

    Affiliation: BioTest Ltd., Konarovice, Czech Republic

    X
  • Oleg Kiselev,

    Affiliation: Influenza Research Institute, Russian Academy of Medical Sciences, St. Petersburg, Russia

    X
  • Thomas Muster,

    Affiliations: Avir Green Hills Biotechnology AG, Vienna, Austria, Division of General Dermatology, Department of Dermatology, Medical University of Vienna, Vienna, Austria

    X
  • Andrej Egorov mail

    a.egorov@greenhillsbiotech.com

    Affiliation: Avir Green Hills Biotechnology AG, Vienna, Austria

    X
  • Published: June 19, 2009
  • DOI: 10.1371/journal.pone.0005984

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.